Akcea Therapeutics and Ambry Genetics are partnering to offer confidential, no-cost genetic testing and confidential counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass program.
To highlight the urgency around early genetic testing, Akcea developed the hATTR Compass Genetic Testing Video Series. These videos feature physician and patient perspectives on the hATTR Compass Program and highlight other patient resources available through hATTR Compass, such as Backpack Health.
hATTR Compass is designed to:
- Help accelerate or confirm the diagnosis of hATTR amyloidosis
- Provide support and resources to patients, caregivers, and healthcare professionals throughout the genetic testing process
- Empower patients and their healthcare providers to make the most informed decisions about their healthcare
The hATTR Compass Program is available for patients in the U.S. and Canada who are 18 years and older and have a family history of hATTR amyloidosis. If there is no family history, the patient must have at least two clinical symptoms or manifestations related to hATTR amyloidosis.
For more information and resources, please visit www.hATTRCompass.com.
Help Your Patients Stay Connected With Backpack Health
Backpack Health is a mobile and web-based app that helps patients keep track of their symptoms, procedures, diagnostic tests, and ongoing treatment for hATTR amyloidosis. The tool also makes it easy for individuals and families navigating the hATTR amyloidosis journey to share important medical information with healthcare professionals. Access to the app is complimentary for patients with hATTR amyloidosis at join.backpackhealth.com/hATTRCompass.